… In the past few years, considerable progress has been made in the treatment of kidney
cancer. Novel treatments targeting molecular pathways known to be dysregulated in this disease …

… risk factors for the development of progressive renal dysfunction. The challenge is to identify
the … The focus of this review will be on selected topics where substantial progress in our …

… in the development of kidney organoid models, including pluripotent stem cell-derived kidney
… Further progress was achieved by selective induction of nephron progenitors, ureteric bud, …

… Thus, checking and maintaining low glycated albumin levels would prevent the formation
of AGE and may be useful to prevent the occurrence or progression of diabetes or …

… The development of in vitro kidney organoids is possible … cellular basis of embryonic kidney
development. Furthermore, the … One area of technology that has seen great progress in the …

… In this review, we introduce the concept and summarize the progress of the current … led to
the creation of various kidney organoids that model kidney development and disease in vitro. …

… Although expression of Upk1b, or any other Upk protein for that matter, has never been
reported during the early stages of kidney development, recent data from our lab show that …

… development that target haemodynamic changes in CKD. Smoking cessation also slows the
rate of progression … address key challenges and considerations in the development of novel …

… important determinants of healthy pregnancies and impact kidney development [15, 99]. These
… Examples of primary kidney diseases that progress more rapidly in patients with low birth …

… In conclusion, in order to address their roles in delaying the development of end-stage
renal disease, atrasentan and finerenone have led to larger phase III trials [75]. And, it was …